Page last updated: 2024-11-05

n-methyl-n-nitrosoaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-N-nitrosoaniline, also known as N-methyl-N-nitrosomethylaniline, is a yellow crystalline solid with a melting point of 59-60 °C. It is a potent carcinogen and mutagen that has been linked to various types of cancer, including bladder cancer. The compound is commonly used as a research tool in the study of nitrosation reactions, which involve the formation of N-nitroso compounds. N-methyl-N-nitrosoaniline is also used as a standard in analytical chemistry. The compound is typically synthesized by reacting N-methylaniline with sodium nitrite in acidic conditions. Its effects on the human body have been extensively studied, revealing its carcinogenic potential through various mechanisms, including DNA alkylation and oxidative stress. The understanding of its mutagenic properties has shed light on the role of nitrosation in human cancer development. Ongoing research focuses on exploring the mechanisms behind its carcinogenic potential and developing strategies to mitigate its harmful effects. The compound serves as a crucial tool for understanding the role of nitrosation in human health and environmental toxicology.'

N-methyl-N-nitrosoaniline: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11957
CHEMBL ID266169
SCHEMBL ID301282
MeSH IDM0062355

Synonyms (57)

Synonym
LS-13273
EN300-18654
methylnitroso phenylamine
brn 1841401
nsc 137
ai3-01373
hsdb 5072
einecs 210-366-5
n-methyl-n-nitrosobenzenamine
ccris 400
methylnitrosoaniline
inchi=1/c7h8n2o/c1-9(8-10)7-5-3-2-4-6-7/h2-6h,1h
n-methyl-n-phenylnitrosoamine
benzenamine, n-methyl-n-nitroso-
n-nitroso-n-methylaniline
614-00-6
n-methyl-n-nitrosoaniline
n-methyl-n-nitrosaniline
wln: onn1&r
n-methyl-n-phenylnitrosamine
nitrosomethylaniline
n-nitrosomethylphenylamine
phenylmethylnitrosamine
aniline, n-methyl-n-nitroso-
nitroso-n-methylaniline
nsc-137
methylphenylnitrosamine
nsc137
n-methyl-n-phenylnitrous amide
CHEMBL266169 ,
N0264
NCGC00249056-01
cas-614-00-6
dtxcid801053
tox21_302747
NCGC00256430-01
dtxsid9021053 ,
NCGC00259059-01
tox21_201508
AKOS008996592
unii-9sm68i29wq
9sm68i29wq ,
FT-0632561
n-methyl-n-nitrosobenzenamine [hsdb]
SCHEMBL301282
methylphenylnitrosamin
1-methyl-2-oxo-1-phenylhydrazine #
MAXCWSIJKVASQC-UHFFFAOYSA-N
1-methyl-2-oxo-1-phenylhydrazine
mfcd00045675
F16699
bdbm50214516
Q27273078
n-methyl-n-nitroso-aniline
SY052228
n-methyl-n-nitrosobenzenamine 100 microg/ml in methanol
Z87001980
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency68.58960.000221.22318,912.5098AID1259243
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159553
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency35.63860.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency50.78100.000229.305416,493.5996AID743069
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (58.33)18.7374
1990's10 (27.78)18.2507
2000's2 (5.56)29.6817
2010's3 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.13 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]